WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17,893	9,173	9,012	13,831	15,490
Short-Term Investments	1,000	1,000	10,500	2,500	3,500
Trading Asset Securities	-	1,019	7,044	26,147	20,444
Cash & Short-Term Investments	18,893	11,192	26,556	42,478	39,435
Cash Growth	68.81%	-57.85%	-37.48%	7.72%	-11.73%
Accounts Receivable	22,105	25,797	17,835	18,635	20,408
Other Receivables	44.94	292.43	47.42	78.45	81.57
Receivables	26,099	30,978	23,372	24,228	26,625
Inventory	16,151	16,004	9,021	8,141	7,922
Prepaid Expenses	24.01	43.49	317.7	1,523	26.92
Other Current Assets	5.21	29.52	183.79	58.6	6.28
Total Current Assets	61,173	58,247	59,451	76,427	74,015
Property, Plant & Equipment	49,236	49,945	39,843	25,379	20,071
Long-Term Investments	11,881	12,099	9,637	8,733	7,209
Other Intangible Assets	4,573	2,532	2,528	1,548	1,542
Long-Term Accounts Receivable	-0	-0	0	-0	0
Long-Term Deferred Tax Assets	1,471	1,198	1,549	1,380	1,459
Long-Term Deferred Charges	6,266	6,315	5,893	5,035	1,408
Other Long-Term Assets	87.95	443.21	493.87	476.13	475.93
Total Assets	134,687	130,780	119,395	118,979	106,180
Accounts Payable	3,620	7,190	3,447	2,435	2,869
Accrued Expenses	1,191	1,066	1,037	1,154	1,085
Short-Term Debt	19,000	11,424	12,519	12,839	10,589
Current Portion of Long-Term Debt	2,333	3,333	2,000	1,000	1,900
Current Portion of Leases	172.04	201.49	172.31	280.27	303.09
Current Income Taxes Payable	298.63	243.82	645.94	761.3	128.5
Other Current Liabilities	7,323	7,552	5,752	5,506	3,475
Total Current Liabilities	33,938	31,011	25,572	23,975	20,349
Long-Term Debt	2,333	4,667	6,600	8,700	4,000
Long-Term Leases	226.39	375.14	175.65	285.61	426.53
Other Long-Term Liabilities	0	0	0	-	0
Total Liabilities	41,571	40,502	36,359	38,074	29,303
Common Stock	2,640	2,640	2,639	2,638	1,758
Additional Paid-In Capital	15,109	15,109	14,997	14,948	15,846
Retained Earnings	74,733	71,894	64,736	62,642	58,880
Treasury Stock	-35.66	-35.66	-35.66	-35.66	-
Comprehensive Income & Other	670.63	670.63	700.16	713.26	393.34
Shareholders' Equity	93,117	90,278	83,036	80,905	76,877
Total Liabilities & Equity	134,687	130,780	119,395	118,979	106,180
Total Debt	24,065	20,001	21,467	23,105	17,219
Net Cash (Debt)	-5,172	-8,809	5,089	19,373	22,216
Net Cash Growth	-	-	-73.73%	-12.80%	-23.81%
Net Cash Per Share	-391.26	-667.36	385.86	1467.59	2685.10
Filing Date Shares Outstanding	13.27	13.2	13.19	13.19	13.19
Total Common Shares Outstanding	13.27	13.2	13.19	13.19	13.19
Working Capital	27,235	27,236	33,878	52,452	53,666
Book Value Per Share	7016.54	6839.41	6295.23	6135.62	5829.05
Tangible Book Value	88,544	87,746	80,508	79,357	75,335
Tangible Book Value Per Share	6671.96	6647.62	6103.58	6018.20	5712.10
Land	6,985	6,985	6,596	6,238	6,238
Buildings	34,896	34,896	10,057	9,657	9,657
Machinery	21,821	18,050	14,250	13,519	12,346
Construction In Progress	79.4	1,976	19,751	5,838	546

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.